Investor's Business Daily
Investor's Business Daily APK
7.8.9 ․ 4 weeks agoFree ․ Investor's Business Daily, Inc ⇣ Download APK (39.08 MB)
Get real-time, actionable analysis with the IBD Stock & Market Analysis App.
What's Investor's Business Daily APK?
Investor's Business Daily is a app for Android, It's developed by Investor's Business Daily, Inc author.
First released on google play in 7 years ago and latest version released in 4 weeks ago.
This app has 390.1K download times on Google play and rated as 4.20 stars with 2,938 rated times.
This product is an app in Finance category. More infomartion of Investor's Business Daily on google play
Winning stock lists, real-time charts and up-to-the-minute market news: now available everywhere, thanks to the newly enhanced Investor’s Business Daily app. The IBD app is free to download.
IBD Digital members will also have access to their favorite premium features, IBD premium lists, charts and personal stock lists. Not an IBD member? You’ll still be able to keep up with market news, videos and information like you would on investors.com.
The IBD app features:
• Callouts of recent chart action for stocks on IBD’s proprietary stock lists.
• Your personal stock lists, now synced across all your devices
• Access to premium features for all IBD Digital members
• Exclusive stock lists like IBD 50, Sector Leaders, IPO Leaders and more
• The latest daily market analysis with The Big Picture and Stock Market Today
• Customizable stock list on the home screen
• Personalized news pages with embedded videos to keep you up-to-date on stocks you’re watching
• Tap stock symbols to see IBD’s exclusive Smart Select Ratings
The IBD app is free to download but IBD Digital subscribers get access to premium ratings and interactive tools. IBD Digital subscription gives you unlimited access to our stock research and analysis across multiple devices - mobile, Mac and PC.
You can purchase a monthly or annual subscription in the IBD app. Both subscriptions come with a one-month free trial and payment will be charged to your Google Play account at the end of the trial period. You may cancel a subscription at any time in your Google Play account settings. Subscriptions auto-renew unless deactivated at least 24-hours before the end of the current period.
If you have any questions about how the app functions or how to access to your subscription on other devices, please contact us at (800) 831-2525 or outside the United States at (310) 448-6600.
IBD Digital members will also have access to their favorite premium features, IBD premium lists, charts and personal stock lists. Not an IBD member? You’ll still be able to keep up with market news, videos and information like you would on investors.com.
The IBD app features:
• Callouts of recent chart action for stocks on IBD’s proprietary stock lists.
• Your personal stock lists, now synced across all your devices
• Access to premium features for all IBD Digital members
• Exclusive stock lists like IBD 50, Sector Leaders, IPO Leaders and more
• The latest daily market analysis with The Big Picture and Stock Market Today
• Customizable stock list on the home screen
• Personalized news pages with embedded videos to keep you up-to-date on stocks you’re watching
• Tap stock symbols to see IBD’s exclusive Smart Select Ratings
The IBD app is free to download but IBD Digital subscribers get access to premium ratings and interactive tools. IBD Digital subscription gives you unlimited access to our stock research and analysis across multiple devices - mobile, Mac and PC.
You can purchase a monthly or annual subscription in the IBD app. Both subscriptions come with a one-month free trial and payment will be charged to your Google Play account at the end of the trial period. You may cancel a subscription at any time in your Google Play account settings. Subscriptions auto-renew unless deactivated at least 24-hours before the end of the current period.
If you have any questions about how the app functions or how to access to your subscription on other devices, please contact us at (800) 831-2525 or outside the United States at (310) 448-6600.
